Inquiry Basket
Loading ......
Creative Diagnostics offers a comprehensive catalog of Transmembrane Proteins Antibodies production, which are custom generated to deliver high specificity, high affinity and robust performance for the detection of complex membrane-associated targets. The immunogenicity and hydrophobic regions inherent to transmembrane proteins create unique challenges in antibody development. Using innovative antigen design, optimized immunization protocols, and stringent screening methods, we develop antibodies with excellent binding to native protein conformations and minimal background. From antigen preparation and hybridoma generation to extensive functional validation, every step of our production process is optimized for consistency and quality. Creative Diagnostics Transmembrane Proteins Antibodies are perfect for a variety of applications including diagnostics, imaging and biosensing, enabling sensitive and accurate detection of membrane-associated biomarkers in a wide range of research and clinical contexts.
Tecan Fluent® Automation Workstation
GE ÄKTA Pure 25
ForteBio Octet® RED96e
Creative Diagnostics offers Transmembrane Proteins Antibody Production Services to help you in your development of high-affinity, high-specificity antibodies for research, diagnostic, and therapeutic use. We have significant experience in both immunology and membrane protein biology, and can design a custom antibody development strategy that addresses the unique structural and biochemical challenges of transmembrane targets. Our production platform includes optimized antigen design, effective immunization strategies, and state-of-the-art screening and validation technologies to ensure the production of robust, reproducible antibodies. These antibodies can be used for a wide range of downstream applications, including ELISA, Western blot, immunohistochemistry, flow cytometry, and biosensor development. We are committed to providing you with reliable, high-performance antibodies with excellent specificity and reproducibility. We provide:
In response to the increased demand for high affinity and highly specific antibodies against membrane bound proteins, we offer Transmembrane Proteins Antibody Production Services. Employing strategies including customized antigen design, improved immunization and purification conditions and advanced screening technologies, we can overcome the challenges presented by transmembrane proteins as targets such as hydrophobicity, low immunogenicity and conformational complexity. This service includes optimized antigen preparation, adjuvant strategies and immunization with full monitoring for increased antibody production and epitope coverage. This platform supports diverse applications including therapeutic antibody candidate screening, membrane biomarker validation, and development of sensitive immunoassays. Supported by a robust quality management system and deep technical expertise, we ensure that every antibody produced demonstrates excellent specificity, stability, and lot-to-lot consistency. Our core services include:
We design precise antigens based on the structural characteristics of target transmembrane proteins (such as extracellular loops, transmembrane regions, specific epitopes, etc.), select peptide antigens, fusion proteins or cell membrane fragments as immunogens, and provide recombinant expression and purification services to ensure that the antigens have high immunogenicity and in situ conformation.
We develop flexible immunization strategies based on customer research needs and antibody uses (such as IHC, WB, Flow, etc.), including immunization animal selection (mice, rats, rabbits, etc.), immunization cycle arrangement, and adjuvant selection (such as CFA, IFA, CpG, etc.) to maximize antibody production and affinity.
We provide efficient hybridoma cell fusion screening platforms (such as HAT screening, ELISA screening, functional verification), develop stable expression, and highly specific monoclonal antibodies, and can also prepare high-titer polyclonal antibodies according to project requirements.
We develop flexible immunization strategies based on customer research needs and antibody uses (such as IHC, WB, Flow, etc.), including immunization animal selection (mice, rats, rabbits, etc.), immunization cycle arrangement, and adjuvant selection (such as CFA, IFA, CpG, etc.) to maximize antibody production and affinity.
We provide efficient hybridoma cell fusion screening platforms (such as HAT screening, ELISA screening, functional verification), develop stable expression, and highly specific monoclonal antibodies, and can also prepare high-titer polyclonal antibodies according to project requirements.
Screen antibodies that recognize natural conformations or membrane epitopes through native antigen coating, flow cytometry analysis, etc., which are suitable for membrane protein function research and targeted verification.
Provide a variety of purification methods (Protein A/G, affinity chromatography, antigen affinity purification, etc.), and provide antibody labeling services (FITC, HRP, Biotin, Cy5, etc.) according to customer needs to meet different experimental types.
We conduct strict functional testing on each batch of antibodies, including ELISA, Western blot, IHC, Flow cytometry and other application verifications, and perform purity analysis, stability testing and batch consistency evaluation to ensure reliable experimental results.
We can provide a variety of delivery methods such as lyophilized powder, liquid antibody, concentrated form, etc., and provide detailed technical reports and usage suggestions to facilitate customers to quickly carry out follow-up research.
Analyze the characteristics of the target membrane protein and determine the immunization requirements.
Develop personalized immunization plans and optimize antigens, animals, doses and adjuvants.
Perform immunization and regularly test antibody levels.
Screen high-affinity and high-specificity antibodies and verify performance.
Mass production of antibodies, purification and technical support.
A Biolayer interferometry (BLI) analysis of the anti-CCR5 mAb. This antibody displays high binding affinity and slow off rates. The concentrations of antibodies tested include 100 nM, 50 nM, 25 nM, 12.5 nM. The rapid association and slow dissociation kinetics can be seen in the above images. The calculated Kd is approximately 0.5 nM. This value indicates that this antibody binds to native CCR5 protein with high affinity.
Whether it is receptors, ion channels, transporters or membrane-bound enzymes, we can help you develop highly specific antibodies to support multiple species and applications.
We will design special antigens, focus on selecting the extracellular region or stable fragments of the protein, and optimize the immunization scheme to ensure that the antibody can accurately bind to the target.
Of course! Whether it is small-scale research and development or large-scale preparation, even antibody labeling, purification or engineering modification, we have mature solutions to support.
To use our transmembrane proteins antibody production services, please contact Creative Diagnostics, your expert immunology service provider. From research-scale transmembrane proteins antibody production to industrial scale-up, our team is ready to support your R&D innovation.
Loading ......
